Large variation in infliximab trough levels is associated with disease activity in paediatric inflammatory bowel disease

被引:2
|
作者
Hoekman, D. [1 ]
Brandse, H. [2 ]
de Meij, T. [3 ]
Hummel, T. [4 ]
Loewenberg, M. [2 ]
Benninga, M. [1 ]
D'Haens, G. [2 ]
Kindermann, A. [1 ]
机构
[1] Univ Amsterdam, Acad Med Ctr, Emma Childrens Hosp, Dept Paediat Gastroenterol & Nutr, NL-1105 AZ Amsterdam, Netherlands
[2] Univ Amsterdam, Acad Med Ctr, Dept Gastroenterol, NL-1105 AZ Amsterdam, Netherlands
[3] Vrije Univ Amsterdam Med Ctr, Pediat Gastoenterol, Amsterdam, Netherlands
[4] Med Spectrum Twente, Pediat Gastoenterol, Enschede, Netherlands
来源
关键词
D O I
10.1016/S1873-9946(14)60067-2
中图分类号
R57 [消化系及腹部疾病];
学科分类号
摘要
DOP042
引用
收藏
页码:S35 / S35
页数:1
相关论文
共 50 条
  • [1] Large Variation in Infliximab Trough Levels Is Associated With Disease Activity in Paediatric Inflammatory Bowel Disease
    Hoekman, Danil R.
    Brandse, Johannan F.
    de Meij, Tim
    Hummel, Thalia
    Lowenberg, M.
    Benninga, Marc A.
    D'Haens, Geert R.
    Kindermann, Angelika
    GASTROENTEROLOGY, 2014, 146 (05) : S782 - S782
  • [2] Infliximab trough levels are associated with disease activity in pediatric inflammatory bowel disease
    Hoekman, D. R.
    Brandse, J. F.
    de Meij, T. G.
    Hummel, T. Z.
    Lowenberg, M.
    Benninga, M. A.
    D'Haens, G. R. A. M.
    Kindermann, A.
    JOURNAL OF CROHNS & COLITIS, 2014, 8 : S412 - S412
  • [3] Higher Infliximab Trough Levels Are Associated With Better Outcome in Paediatric Patients With Inflammatory Bowel Disease
    van Hoeve, Karen
    Dreesen, Erwin
    Hoffman, Ilse
    Van Assche, Gert
    Ferrante, Marc
    Gils, Ann
    Vermeire, Severine
    JOURNAL OF CROHNS & COLITIS, 2018, 12 (11): : 1316 - 1325
  • [4] The association of infliximab trough levels with disease activity in pediatric inflammatory bowel disease
    Hoekman, Daniel R.
    Brandse, Johannan F.
    de Meij, Tim G.
    Hummel, Thalia Z.
    Lowenberg, Mark
    Benninga, Marc A.
    D'Haens, Geert R.
    Kindermann, Angelika
    SCANDINAVIAN JOURNAL OF GASTROENTEROLOGY, 2015, 50 (09) : 1110 - 1117
  • [5] Serum trough levels of infliximab are not associated with peripheral arthralgia activity in patients with inflammatory bowel disease
    Sekhri, Shaina
    Rao, Bharat
    Mohananey, Akanksha
    Beniwal-Patel, Poonam
    Bruss, Alexandra
    Stein, Daniel J.
    Yarur, Andres J.
    BMJ OPEN GASTROENTEROLOGY, 2021, 8 (01):
  • [6] Infliximab trough levels during maintenance are predictive for infliximab efficacy in paediatric patients with inflammatory bowel disease
    van Hoeve, K.
    Hoffman, I.
    Dreesen, E.
    Ferrante, M.
    Gils, A.
    Vermeire, S.
    JOURNAL OF CROHNS & COLITIS, 2018, 12 : S180 - S181
  • [7] Infliximab Trough Levels Are Associated With Transmural Sonographic Healing in Inflammatory Bowel Disease
    Vaughan, Rose
    Murphy, Elise
    Nalder, Michelle
    Gibson, Robert N.
    Ardalan, Zaid
    Boussioutas, Alex
    Christensen, Britt
    INFLAMMATORY BOWEL DISEASES, 2023, 29 (07) : 1080 - 1088
  • [8] Infliximab trough levels after induction therapy are predictive for infliximab efficacy in paediatric patients with inflammatory bowel disease
    van Hoeve, K.
    Hoffman, I.
    Dreesen, E.
    Ferrante, M.
    Gils, A.
    Vermeire, S.
    JOURNAL OF CROHNS & COLITIS, 2018, 12 : S183 - S183
  • [9] ANTIBODIES TO INFLIXIMAB AND INFLIXIMAB TROUGH LEVELS IN THE MANAGEMENT OF CHILDREN WITH INFLAMMATORY BOWEL DISEASE
    Dilillo, A.
    Isoldi, S.
    Mallardo, S.
    Civitelli, F.
    Oliva, S.
    Aloi, M.
    Rossi, P.
    Carbogno, S.
    Viola, F.
    Cucchiara, S.
    DIGESTIVE AND LIVER DISEASE, 2016, 48 : E271 - E271
  • [10] High infliximab trough levels are associated with better control of inflammation in inflammatory bowel disease
    Drobne, D.
    Kurent, T.
    Rajar, P.
    Slak, M.
    Kozelj, M.
    Novak, G.
    Smrekar, N.
    Plut, S.
    Smid, A.
    Osredkar, J.
    Stabuc, B.
    Ferkolj, I.
    JOURNAL OF CROHNS & COLITIS, 2016, 10 : S249 - S250